CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Find Roth IRA index funds with the lowest fees to keep more of your returns. Compare expense ratios and pick a cost-efficient fund for long-term growth.
27,085 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Joby Aviation posted record Q4 2025 revenue driven by the Blade acquisition, but the stock remains volatile as cash b...
A rising demand for organ preservation and transplant networks could power meaningful upside in this healthcare infra...
Investors are buzzing about Revolution Medicines this year as its RAS-focused cancer programs advance. This article l...
In May, Marvell Technology delivered more than a beat on sentiment, aided by AI infrastructure demand and a strategic...
As Skillsoft charts a path toward 2027 earnings growth, investors should weigh subscription momentum, retention, and ...
As HOFT releases its Q1 2027 earnings, investors should focus on revenue trends, margins, and demand signals. This gu...
Artificial intelligence is reshaping markets, and Anthropic's latest Fable model adds fuel to the fire. This guide br...
SpaceX has sprinted out of the gate after its IPO, up roughly 49% from the offer price. As December approaches, inves...
Travel rewards can feel like extra money in your pocket, but taxes can complicate the picture. This guide explains wh...
Cerebras Systems stock crashed after its latest earnings report, leaving investors asking what happened and what come...
As AI chip fears rattled markets, microsoft stock rose today thanks to cloud momentum, AI software adoption, and stro...